Elevated serum heparanase-1 levels in patients with pancreatic carcinoma are associated with poor survival.
Elevated serum heparanase-1 levels in patients with pancreatic carcinoma are associated with poor survival. Cancer. 2006 Feb 01; 106(3):532-40.